Apogee Therapeutics, Inc. (APGE)

NASDAQ: APGE · Real-Time Price · USD

37.13

-1.03 (-2.70%)

At close: Sep 4, 2025, 4:00 PM

37.13

0.00 (0.00%)

After-hours: Sep 4, 2025, 4:00 PM EDT

Apogee Therapeutics Employees

Apogee Therapeutics had 196 employees as of December 31, 2024. The number of employees increased by 105 or 115.38% compared to the previous year.

Employees

196

Change (1Y)

105

Growth (1Y)

115.38%

Revenue / Employee

n/a

Profits / Employee

-$1,212,607

Market Cap

2.17B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	196	105	115.38%
Dec 31, 2023	91	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

APGE News

1 day ago - Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum - GlobeNewsWire
24 days ago - Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
2 months ago - Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis - Seeking Alpha
2 months ago - Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis - GlobeNewsWire
2 months ago - Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025 - GlobeNewsWire
3 months ago - Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference - GlobeNewsWire
4 months ago - Apogee Therapeutics: APG808 Asthma Treatment May Overtake Dupixent In IL-4Rα Class - Seeking Alpha
4 months ago - Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results - GlobeNewsWire